EndoChoice announces completion of Series B financing

EndoChoice, Inc., an emerging leader in GI endoscopy products and services, announced today that it completed its Series B financing. The financing was co-led by Council Ventures and Series A lead investor River Cities Capital Funds. With more than 500 GI products and services, EndoChoice is bringing new efficiencies and innovation to the GI professional.

EndoChoice will use the funds to expand their existing team in the US, Europe and Asia, to accelerate growth as they launch new technology and services. "We are excited to enter the next phase of our dramatic growth and are pleased to have partnered with two world-class venture capital firms," said Mark Gilreath, founder and chief executive officer of EndoChoice.

"The GI market has long suffered from a lack of innovation and high quality service," said Grant Jackson, General Partner at Council Ventures. "We are excited to be an investor in EndoChoice and to back an excellent management team with strong experience in GI as they bring needed innovation to the GI space."

"EndoChoice has proven that there is significant need in the marketplace for their offering as evidenced by rapid growth, customer praise and industry accolades. We are pleased to continue to support the management team in their endeavor to build an industry leading medtech company," said Rik Vandevenne, Principal, River Cities Capital Funds.